According to a May 6, 2005 report in the Los Angeles Times, a Merck company bulletin from 2001 ordered the sales force to steer clear of discussing a scientific meeting convened by the Food and Drug Administration to evaluate Vioxx safety. "DO NOT INITIATE DISCUSSIONS," it said in a prominent warning. In other internal missives, concerns about heart risks were termed "obstacles." A sales campaign to overcome the safety concerns was called "Project Offense." Another was dubbed "Project XXceleration"--a play on the spelling of the drug.
Now one of the top on-line publishers in the world, LifeTips offers tips to millions of monthly visitors. Our mission mission is to make your life smarter, better, faster and wiser. Expert writers earn dough for what they know. And exclusive sponsors in each niche topic help us make-it-all happen.